⌘K

Home/Filings/4/0001415889-23-015909

4//SEC Filing

Coen Stacy Ann 4

Accession 0001415889-23-015909

CIK 0000855654other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 9:08 PM ET

Size

4.7 KB

Accession

0001415889-23-015909

Insider Transaction Report

Form 4

Period: 2023-11-30

ImmunoGen, Inc.IMGN

Chief Business Officer

Transactions

Sale
Common Stock
2023-11-30$29.20/sh−3,826$111,719→ 33,140 total

Footnotes (1)

[F1]Effected pursuant to a trading plan adopted on August 10, 2023 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Documents

1 file

4
form4-12062023_021256.xmlPrimary

Issuer

ImmunoGen, Inc.

CIK 0000855654

Entity typeother

Related Parties

1

filerCIK 0001814150

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 9:08 PM ET
Size: 4.7 KB

View on SEC.gov